Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

2.

National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.

Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP; San Antonio Heart Study.

Circulation. 2004 Sep 7;110(10):1251-7. Epub 2004 Aug 23.

3.

All-cause and cardiovascular mortality using the different definitions of metabolic syndrome.

Benetos A, Thomas F, Pannier B, Bean K, Jégo B, Guize L.

Am J Cardiol. 2008 Jul 15;102(2):188-91. doi: 10.1016/j.amjcard.2008.03.037. Epub 2008 May 28.

PMID:
18602519
4.
5.

Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.

de Simone G, Devereux RB, Chinali M, Best LG, Lee ET, Galloway JM, Resnick HE; Strong Heart Study Investigators.

Diabetes Care. 2007 Jul;30(7):1851-6. Epub 2007 Apr 17.

PMID:
17440172
7.

The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.

Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ.

J Am Coll Cardiol. 2010 Sep 28;56(14):1113-32. doi: 10.1016/j.jacc.2010.05.034. Review.

8.

Metabolic syndrome and risk of cardiovascular disease: a meta-analysis.

Galassi A, Reynolds K, He J.

Am J Med. 2006 Oct;119(10):812-9.

PMID:
17000207
9.

The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men.

Katzmarzyk PT, Janssen I, Ross R, Church TS, Blair SN.

Diabetes Care. 2006 Feb;29(2):404-9.

PMID:
16443895
10.

Prediction of cardiovascular and total mortality in Chinese type 2 diabetic patients by the WHO definition for the metabolic syndrome.

Ko GT, So WY, Chan NN, Chan WB, Tong PC, Li J, Yeung V, Chow CC, Ozaki R, Ma RC, Cockram CS, Chan JC.

Diabetes Obes Metab. 2006 Jan;8(1):94-104.

PMID:
16367887
11.

The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.

Wang J, Ruotsalainen S, Moilanen L, Lepistö P, Laakso M, Kuusisto J.

Eur Heart J. 2007 Apr;28(7):857-64. Epub 2007 Feb 15.

PMID:
17303589
12.

[Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].

Vanuzzo D, Pilotto L, Mirolo R, Pirelli S.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):6S-17S. Review. Italian.

PMID:
18773746
13.

Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes.

Thorn LM, Forsblom C, Wadén J, Saraheimo M, Tolonen N, Hietala K, Groop PH; Finnish Diabetic Nephropathy (FinnDiane) Study Group.

Diabetes Care. 2009 May;32(5):950-2. doi: 10.2337/dc08-2022. Epub 2009 Feb 5.

14.

Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study.

Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Runzo C, Prina Cerai S, Pagano G, Cavallo-Perin P; Casale Monferrato Study.

Diabetes Care. 2004 Nov;27(11):2689-94.

PMID:
15505006
15.

The metabolic syndrome and cardiovascular risk.

Hu G, Qiao Q, Tuomilehto J.

Curr Diabetes Rev. 2005 May;1(2):137-43. Review.

PMID:
18220589
16.

The effects of pre-disease risk factors within metabolic syndrome on all-cause and cardiovascular disease mortality.

Tsai SP, Wen CP, Chan HT, Chiang PH, Tsai MK, Cheng TY.

Diabetes Res Clin Pract. 2008 Oct;82(1):148-56. doi: 10.1016/j.diabres.2008.07.016. Epub 2008 Aug 30.

PMID:
18757109
17.

All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.

Doshi KB, Kashyap SR, Brennan DM, Hoar BM, Cho L, Hoogwerf BJ.

Diabetes Obes Metab. 2009 Feb;11(2):102-8. doi: 10.1111/j.1463-1326.2008.00908.x. Epub 2008 May 20.

PMID:
18494803
19.

Health and mortality consequences of abdominal obesity: evidence from the AusDiab study.

Cameron AJ, Dunstan DW, Owen N, Zimmet PZ, Barr EL, Tonkin AM, Magliano DJ, Murray SG, Welborn TA, Shaw JE.

Med J Aust. 2009 Aug 17;191(4):202-8.

PMID:
19705980
20.

Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study.

Henderson DC, Nguyen DD, Copeland PM, Hayden DL, Borba CP, Louie PM, Freudenreich O, Evins AE, Cather C, Goff DC.

J Clin Psychiatry. 2005 Sep;66(9):1116-21.

PMID:
16187768

Supplemental Content

Support Center